Professional
Added to YB: 2024-05-30
Pitch date: 2024-05-15
NTRA [bullish]
Natera, Inc.
+90.88%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide.
Market Cap
$28.0B
Pitch Price
$106.71
Price Target
N/A
Dividend
N/A
EV/EBITDA
-110.32
P/E
-119.45
EV/Sales
10.85
Sector
Biotechnology
Category
growth
Show full summary:
Parnassus Growth Equity Fund New Position: Natera, Inc.
NTRA: Genetic testing co. in women's health, oncology & organ transplant. Upside from wider test adoption, coverage expansion & new products. Strong mgmt to reach CF breakeven in '23 while balancing growth & profits.
Read full article (1 min)